About: Aliskiren/hydrochlorothiazide

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Aliskiren/hydrochlorothiazide, sold under the brand name Tekturna HCT among others, is a fixed-dose combination medication for the treatment of hypertension (high blood pressure). It contains aliskiren, a renin inhibitor, and hydrochlorothiazide, a diuretic. It is taken by mouth. The most common side effect is diarrhea. Aliskiren/hydrochlorothiazide was approved for medical use in the United States in January 2008, and for use in the European Union in January 2009.

Property Value
dbo:abstract
  • Aliskiren/hydrochlorothiazide, sold under the brand name Tekturna HCT among others, is a fixed-dose combination medication for the treatment of hypertension (high blood pressure). It contains aliskiren, a renin inhibitor, and hydrochlorothiazide, a diuretic. It is taken by mouth. The most common side effect is diarrhea. Aliskiren/hydrochlorothiazide was approved for medical use in the United States in January 2008, and for use in the European Union in January 2009. (en)
dbo:alternativeName
  • Tekturna HCT, Rasilez HCT, others (en)
dbo:kegg
  • D10289
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 65089520 (xsd:integer)
dbo:wikiPageLength
  • 5797 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1074065700 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • 9.0
dbp:atcSuffix
  • XA52 (en)
dbp:class
dbp:component
  • Hydrochlorothiazide (en)
  • Aliskiren (en)
dbp:dailymedid
  • Aliskiren_hemifumarate_and_hydrochlorothiazide (en)
dbp:kegg
  • D10289 (en)
dbp:legalEu
  • Rx-only (en)
dbp:legalUs
  • Rx-only (en)
dbp:routesOfAdministration
dbp:tradename
  • Tekturna HCT, Rasilez HCT, others (en)
dbp:type
  • combo (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Aliskiren/hydrochlorothiazide, sold under the brand name Tekturna HCT among others, is a fixed-dose combination medication for the treatment of hypertension (high blood pressure). It contains aliskiren, a renin inhibitor, and hydrochlorothiazide, a diuretic. It is taken by mouth. The most common side effect is diarrhea. Aliskiren/hydrochlorothiazide was approved for medical use in the United States in January 2008, and for use in the European Union in January 2009. (en)
rdfs:label
  • Aliskiren/hydrochlorothiazide (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License